Tools & Techniques
| 5 min read
Wobble Genomics is using long-read RNA sequencing to reveal the molecular signals that determine whether a cancer treatment will work.
As flow cytometry panels grow larger and more complex, thoughtful panel design has become critical for experimental success.
| 2 min read
The expanded service brings 10x Genomics-powered single-cell RNA sequencing to Novogene Europe's Cambridge Omics Centre, providing UK researchers with local access to end-to-end workflows and bioinformatics support.
| 6 min read
Phase Advance is using mechanistic virtual patient models to predict how LEAF4Life's hypoxia-targeting therapy could perform across multiple indications.
| 3 min read
Researchers find that infant airway tissue actively shapes the immune response to RSV, suggesting future therapies should target both the virus and inflammation.
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
| 5 min read
Aurion Biotech's manufacturing approach to unmodified allogeneic corneal endothelial cells offers a set of hard-won lessons for a cell therapy field still working out how to get from proof-of-concept to broad patient access.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Automated mass photometry helps reveal the complex dynamics of protein oligomerization and the factors that govern protein assembly.
| 2 min read
The new service adds metabolite profiling to Novogene Europe's genomics and transcriptomics capabilities, supporting integrated multiomics research.
| 5 min read
High-throughput screening has always been about speed and volume. As assays grow more biologically complex, the harder question is whether the data they generate can actually be trusted at scale.
| 6 min read
As soaring costs and logistical complexity strain traditional cell therapy models, in vivo CAR T is prompting a fundamental rethink of how advanced therapies are manufactured and scaled.
